JP5359059B2 - Antibacterial film forming agent for outer skin - Google Patents
Antibacterial film forming agent for outer skin Download PDFInfo
- Publication number
- JP5359059B2 JP5359059B2 JP2008168381A JP2008168381A JP5359059B2 JP 5359059 B2 JP5359059 B2 JP 5359059B2 JP 2008168381 A JP2008168381 A JP 2008168381A JP 2008168381 A JP2008168381 A JP 2008168381A JP 5359059 B2 JP5359059 B2 JP 5359059B2
- Authority
- JP
- Japan
- Prior art keywords
- film
- forming agent
- skin
- outer skin
- antibacterial film
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 230000000844 anti-bacterial effect Effects 0.000 title claims description 73
- 239000003795 chemical substances by application Substances 0.000 claims abstract description 66
- ZSZRUEAFVQITHH-UHFFFAOYSA-N 2-(2-methylprop-2-enoyloxy)ethyl 2-(trimethylazaniumyl)ethyl phosphate Chemical compound CC(=C)C(=O)OCCOP([O-])(=O)OCC[N+](C)(C)C ZSZRUEAFVQITHH-UHFFFAOYSA-N 0.000 claims abstract description 60
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims abstract description 33
- 239000000178 monomer Substances 0.000 claims abstract description 33
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 18
- 229920001577 copolymer Polymers 0.000 claims abstract description 17
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims abstract description 12
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 claims abstract description 10
- 125000001165 hydrophobic group Chemical group 0.000 claims abstract description 8
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims abstract description 5
- 125000000217 alkyl group Chemical group 0.000 claims abstract description 4
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims abstract description 4
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 claims abstract description 4
- 239000003899 bactericide agent Substances 0.000 claims description 5
- 150000001298 alcohols Chemical class 0.000 claims description 3
- 125000004432 carbon atom Chemical group C* 0.000 claims description 3
- 241000233866 Fungi Species 0.000 abstract description 6
- 230000002538 fungal effect Effects 0.000 abstract description 2
- 230000000843 anti-fungal effect Effects 0.000 abstract 3
- 229940121375 antifungal agent Drugs 0.000 abstract 3
- 210000002615 epidermis Anatomy 0.000 abstract 2
- 230000002401 inhibitory effect Effects 0.000 abstract 1
- 230000003449 preventive effect Effects 0.000 abstract 1
- 210000003491 skin Anatomy 0.000 abstract 1
- 229920000642 polymer Polymers 0.000 description 34
- 238000011156 evaluation Methods 0.000 description 18
- NIXOWILDQLNWCW-UHFFFAOYSA-M Acrylate Chemical compound [O-]C(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-M 0.000 description 17
- 239000000203 mixture Substances 0.000 description 17
- SOGAXMICEFXMKE-UHFFFAOYSA-N Butylmethacrylate Chemical compound CCCCOC(=O)C(C)=C SOGAXMICEFXMKE-UHFFFAOYSA-N 0.000 description 16
- -1 2-ethylhexyl Chemical group 0.000 description 11
- 230000003405 preventing effect Effects 0.000 description 10
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 8
- 230000010065 bacterial adhesion Effects 0.000 description 8
- 238000001035 drying Methods 0.000 description 8
- 238000000034 method Methods 0.000 description 8
- 230000002265 prevention Effects 0.000 description 8
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 7
- 230000000694 effects Effects 0.000 description 7
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 6
- 238000002156 mixing Methods 0.000 description 6
- 241000894006 Bacteria Species 0.000 description 5
- 230000015572 biosynthetic process Effects 0.000 description 5
- 230000000052 comparative effect Effects 0.000 description 5
- 239000008213 purified water Substances 0.000 description 5
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 4
- 235000011187 glycerol Nutrition 0.000 description 4
- 239000004615 ingredient Substances 0.000 description 4
- 239000007788 liquid Substances 0.000 description 4
- 239000000843 powder Substances 0.000 description 4
- 238000002360 preparation method Methods 0.000 description 4
- 239000000243 solution Substances 0.000 description 4
- 238000003756 stirring Methods 0.000 description 4
- 239000000080 wetting agent Substances 0.000 description 4
- NJNWCIAPVGRBHO-UHFFFAOYSA-N 2-hydroxyethyl-dimethyl-[(oxo-$l^{5}-phosphanylidyne)methyl]azanium Chemical group OCC[N+](C)(C)C#P=O NJNWCIAPVGRBHO-UHFFFAOYSA-N 0.000 description 3
- 239000000654 additive Substances 0.000 description 3
- GMSCBRSQMRDRCD-UHFFFAOYSA-N dodecyl 2-methylprop-2-enoate Chemical compound CCCCCCCCCCCCOC(=O)C(C)=C GMSCBRSQMRDRCD-UHFFFAOYSA-N 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- HMZGPNHSPWNGEP-UHFFFAOYSA-N octadecyl 2-methylprop-2-enoate Chemical compound CCCCCCCCCCCCCCCCCCOC(=O)C(C)=C HMZGPNHSPWNGEP-UHFFFAOYSA-N 0.000 description 3
- 229920001451 polypropylene glycol Polymers 0.000 description 3
- 239000007787 solid Substances 0.000 description 3
- 229940058015 1,3-butylene glycol Drugs 0.000 description 2
- SVTBMSDMJJWYQN-UHFFFAOYSA-N 2-methylpentane-2,4-diol Chemical compound CC(O)CC(C)(C)O SVTBMSDMJJWYQN-UHFFFAOYSA-N 0.000 description 2
- XPFCZYUVICHKDS-UHFFFAOYSA-N 3-methylbutane-1,3-diol Chemical compound CC(C)(O)CCO XPFCZYUVICHKDS-UHFFFAOYSA-N 0.000 description 2
- XKRFYHLGVUSROY-UHFFFAOYSA-N Argon Chemical compound [Ar] XKRFYHLGVUSROY-UHFFFAOYSA-N 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- 239000000443 aerosol Substances 0.000 description 2
- 239000007864 aqueous solution Substances 0.000 description 2
- 238000005452 bending Methods 0.000 description 2
- 235000019437 butane-1,3-diol Nutrition 0.000 description 2
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 2
- YZIYKJHYYHPJIB-UUPCJSQJSA-N chlorhexidine gluconate Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O.C1=CC(Cl)=CC=C1NC(=N)NC(=N)NCCCCCCNC(=N)NC(=N)NC1=CC=C(Cl)C=C1 YZIYKJHYYHPJIB-UUPCJSQJSA-N 0.000 description 2
- 229960003333 chlorhexidine gluconate Drugs 0.000 description 2
- 239000011248 coating agent Substances 0.000 description 2
- 238000007334 copolymerization reaction Methods 0.000 description 2
- 239000000645 desinfectant Substances 0.000 description 2
- SZXQTJUDPRGNJN-UHFFFAOYSA-N dipropylene glycol Chemical compound OCCCOCCCO SZXQTJUDPRGNJN-UHFFFAOYSA-N 0.000 description 2
- 125000003438 dodecyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 2
- 238000010528 free radical solution polymerization reaction Methods 0.000 description 2
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 2
- 230000001771 impaired effect Effects 0.000 description 2
- 229910010272 inorganic material Inorganic materials 0.000 description 2
- OKJPEAGHQZHRQV-UHFFFAOYSA-N iodoform Chemical compound IC(I)I OKJPEAGHQZHRQV-UHFFFAOYSA-N 0.000 description 2
- 239000002649 leather substitute Substances 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 239000007921 spray Substances 0.000 description 2
- 125000004079 stearyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 2
- 238000004659 sterilization and disinfection Methods 0.000 description 2
- 239000000758 substrate Substances 0.000 description 2
- 229940043375 1,5-pentanediol Drugs 0.000 description 1
- CPKVUHPKYQGHMW-UHFFFAOYSA-N 1-ethenylpyrrolidin-2-one;molecular iodine Chemical compound II.C=CN1CCCC1=O CPKVUHPKYQGHMW-UHFFFAOYSA-N 0.000 description 1
- QTWJRLJHJPIABL-UHFFFAOYSA-N 2-methylphenol;3-methylphenol;4-methylphenol Chemical compound CC1=CC=C(O)C=C1.CC1=CC=CC(O)=C1.CC1=CC=CC=C1O QTWJRLJHJPIABL-UHFFFAOYSA-N 0.000 description 1
- IJALWSVNUBBQRA-UHFFFAOYSA-N 4-Isopropyl-3-methylphenol Chemical compound CC(C)C1=CC=C(O)C=C1C IJALWSVNUBBQRA-UHFFFAOYSA-N 0.000 description 1
- 229940123208 Biguanide Drugs 0.000 description 1
- GHXZTYHSJHQHIJ-UHFFFAOYSA-N Chlorhexidine Chemical compound C=1C=C(Cl)C=CC=1NC(N)=NC(N)=NCCCCCCN=C(N)N=C(N)NC1=CC=C(Cl)C=C1 GHXZTYHSJHQHIJ-UHFFFAOYSA-N 0.000 description 1
- 208000035473 Communicable disease Diseases 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- 239000004908 Emulsion polymer Substances 0.000 description 1
- 239000004386 Erythritol Substances 0.000 description 1
- UNXHWFMMPAWVPI-UHFFFAOYSA-N Erythritol Natural products OCC(O)C(O)CO UNXHWFMMPAWVPI-UHFFFAOYSA-N 0.000 description 1
- 229920002153 Hydroxypropyl cellulose Polymers 0.000 description 1
- 229930195725 Mannitol Natural products 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- 229920000153 Povidone-iodine Polymers 0.000 description 1
- FOIXSVOLVBLSDH-UHFFFAOYSA-N Silver ion Chemical compound [Ag+] FOIXSVOLVBLSDH-UHFFFAOYSA-N 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 238000004873 anchoring Methods 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 230000002421 anti-septic effect Effects 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 229910052786 argon Inorganic materials 0.000 description 1
- 239000012298 atmosphere Substances 0.000 description 1
- 230000003385 bacteriostatic effect Effects 0.000 description 1
- 229960000686 benzalkonium chloride Drugs 0.000 description 1
- UREZNYTWGJKWBI-UHFFFAOYSA-M benzethonium chloride Chemical compound [Cl-].C1=CC(C(C)(C)CC(C)(C)C)=CC=C1OCCOCC[N+](C)(C)CC1=CC=CC=C1 UREZNYTWGJKWBI-UHFFFAOYSA-M 0.000 description 1
- 229960001950 benzethonium chloride Drugs 0.000 description 1
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 description 1
- CADWTSSKOVRVJC-UHFFFAOYSA-N benzyl(dimethyl)azanium;chloride Chemical compound [Cl-].C[NH+](C)CC1=CC=CC=C1 CADWTSSKOVRVJC-UHFFFAOYSA-N 0.000 description 1
- 239000007853 buffer solution Substances 0.000 description 1
- WERYXYBDKMZEQL-UHFFFAOYSA-N butane-1,4-diol Chemical compound OCCCCO WERYXYBDKMZEQL-UHFFFAOYSA-N 0.000 description 1
- 239000003093 cationic surfactant Substances 0.000 description 1
- 229960001927 cetylpyridinium chloride Drugs 0.000 description 1
- YMKDRGPMQRFJGP-UHFFFAOYSA-M cetylpyridinium chloride Chemical compound [Cl-].CCCCCCCCCCCCCCCC[N+]1=CC=CC=C1 YMKDRGPMQRFJGP-UHFFFAOYSA-M 0.000 description 1
- 229960003260 chlorhexidine Drugs 0.000 description 1
- 239000011247 coating layer Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 238000004040 coloring Methods 0.000 description 1
- 229930003836 cresol Natural products 0.000 description 1
- 125000000113 cyclohexyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 description 1
- 208000002925 dental caries Diseases 0.000 description 1
- 230000000249 desinfective effect Effects 0.000 description 1
- 229940105990 diglycerin Drugs 0.000 description 1
- GPLRAVKSCUXZTP-UHFFFAOYSA-N diglycerol Chemical compound OCC(O)COCC(O)CO GPLRAVKSCUXZTP-UHFFFAOYSA-N 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 238000007720 emulsion polymerization reaction Methods 0.000 description 1
- 235000019414 erythritol Nutrition 0.000 description 1
- UNXHWFMMPAWVPI-ZXZARUISSA-N erythritol Chemical compound OC[C@H](O)[C@H](O)CO UNXHWFMMPAWVPI-ZXZARUISSA-N 0.000 description 1
- 229940009714 erythritol Drugs 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- 239000006260 foam Substances 0.000 description 1
- 239000004088 foaming agent Substances 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 229940051250 hexylene glycol Drugs 0.000 description 1
- 229960000443 hydrochloric acid Drugs 0.000 description 1
- 239000001863 hydroxypropyl cellulose Substances 0.000 description 1
- 235000010977 hydroxypropyl cellulose Nutrition 0.000 description 1
- 229940071676 hydroxypropylcellulose Drugs 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 239000011261 inert gas Substances 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 150000002484 inorganic compounds Chemical class 0.000 description 1
- 239000011147 inorganic material Substances 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- XMBWDFGMSWQBCA-UHFFFAOYSA-M iodide Chemical compound [I-] XMBWDFGMSWQBCA-UHFFFAOYSA-M 0.000 description 1
- 150000002497 iodine compounds Chemical class 0.000 description 1
- NFIDBGJMFKNGGQ-UHFFFAOYSA-N isopropylmethylphenol Natural products CC(C)CC1=CC=CC=C1O NFIDBGJMFKNGGQ-UHFFFAOYSA-N 0.000 description 1
- 230000001050 lubricating effect Effects 0.000 description 1
- 239000000845 maltitol Substances 0.000 description 1
- 235000010449 maltitol Nutrition 0.000 description 1
- VQHSOMBJVWLPSR-WUJBLJFYSA-N maltitol Chemical compound OC[C@H](O)[C@@H](O)[C@@H]([C@H](O)CO)O[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O VQHSOMBJVWLPSR-WUJBLJFYSA-N 0.000 description 1
- 229940035436 maltitol Drugs 0.000 description 1
- 239000000594 mannitol Substances 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- 229960001855 mannitol Drugs 0.000 description 1
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 239000012046 mixed solvent Substances 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- AZJXQVRPBZSNFN-UHFFFAOYSA-N octane-3,3-diol Chemical compound CCCCCC(O)(O)CC AZJXQVRPBZSNFN-UHFFFAOYSA-N 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- WCVRQHFDJLLWFE-UHFFFAOYSA-N pentane-1,2-diol Chemical compound CCCC(O)CO WCVRQHFDJLLWFE-UHFFFAOYSA-N 0.000 description 1
- 150000002978 peroxides Chemical class 0.000 description 1
- 239000011941 photocatalyst Substances 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 229920006254 polymer film Polymers 0.000 description 1
- 238000006116 polymerization reaction Methods 0.000 description 1
- 229920005862 polyol Polymers 0.000 description 1
- 239000000244 polyoxyethylene sorbitan monooleate Substances 0.000 description 1
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 description 1
- 229920000053 polysorbate 80 Polymers 0.000 description 1
- 229940068968 polysorbate 80 Drugs 0.000 description 1
- 229960001621 povidone-iodine Drugs 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 239000007870 radical polymerization initiator Substances 0.000 description 1
- 239000003352 sequestering agent Substances 0.000 description 1
- 230000037380 skin damage Effects 0.000 description 1
- 230000005808 skin problem Effects 0.000 description 1
- 239000000344 soap Substances 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 229960002920 sorbitol Drugs 0.000 description 1
- 235000010356 sorbitol Nutrition 0.000 description 1
- 238000005507 spraying Methods 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 238000010557 suspension polymerization reaction Methods 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- 230000005068 transpiration Effects 0.000 description 1
- 239000008215 water for injection Substances 0.000 description 1
- 239000000811 xylitol Substances 0.000 description 1
- 235000010447 xylitol Nutrition 0.000 description 1
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 description 1
- 229960002675 xylitol Drugs 0.000 description 1
Landscapes
- Materials For Medical Uses (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Compositions Of Macromolecular Compounds (AREA)
- Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
Abstract
Description
本発明は、耐久性の高い皮膜を皮膚に形成することができる、菌付着防止性に優れた、菌付着そのものを抑制する全く新しい外皮用防菌皮膜形成剤に関する。 The present invention relates to a completely new antibacterial film-forming agent for outer skin that can form a highly durable film on the skin, has excellent antibacterial adhesion prevention properties, and suppresses bacterial adhesion itself.
近年、病原性ウイルスや細菌類による感染症の拡大が懸念されており、各種感染防止関連製品の開発が行われている。中でも、手指用殺菌消毒剤は、使用時に手指に塗布または噴霧するだけで殺菌消毒でき、タオルで拭取る必要が無い等の利点を有し、医療機関をはじめとして広く普及している。しかし、上記殺菌消毒剤は、殺菌成分としてアルコールや逆性石鹸などを含むため、これらの成分に過敏な反応を示す患者や、日常的にこれを使用する看護師らに対して皮膚障害を誘発する場合があった。また、殺菌成分の多くは効果が即時的であり、抗菌活性の持続性はなかった。 In recent years, there is concern about the spread of infectious diseases caused by pathogenic viruses and bacteria, and various infection prevention related products are being developed. Among them, hand sterilizers have the advantage that they can be sterilized and disinfected by simply applying or spraying them on the fingers during use, and do not need to be wiped off with towels. However, the above-mentioned disinfectant contains alcohol, reverse soap, etc. as disinfecting ingredients, so it induces skin damage to patients who are sensitive to these ingredients and nurses who use them on a daily basis. There was a case. In addition, many of the bactericidal components have an immediate effect and have no antibacterial activity.
特許文献1によれば、2−メタクリロイルオキシエチルホスホリルコリンと疎水性基含有単量体の共重合物は生化学用プレートのコーティング剤などに応用されており、蛋白質や微生物の付着を抑制する効果が知られているが、これは、2−メタクリロイルオキシエチルホスホリルコリンと疎水性基含有単量体の共重合物をコーティングした材料表面が緩衝溶液や培地などの液体によって濡れた状態で潤滑機能を発現する医用基材に関するものである。 According to Patent Document 1, a copolymer of 2-methacryloyloxyethyl phosphorylcholine and a hydrophobic group-containing monomer is applied to a coating agent for biochemical plates, and has the effect of suppressing the adhesion of proteins and microorganisms. As is known, this exhibits a lubricating function when the surface of a material coated with a copolymer of 2-methacryloyloxyethyl phosphorylcholine and a hydrophobic group-containing monomer is wetted by a liquid such as a buffer solution or a medium. The present invention relates to a medical substrate.
また、防菌皮膜形成を特徴とする発明として、特許文献2には、無機系材粉末80%〜97%と、無機銅粉末20%〜3%を混合したことを特徴とする防カビ及び抗菌組成物がある。しかし、皮膚に用いることはできない。特許文献3には、水溶性および/または水性エマルジョン性重合体よりなる皮膜を形成するための、う蝕防止用歯科用組成物があるが、手指などの外皮に用いることはできない。特許文献4には、乾燥によって透明な、耐久性の高い皮膜を基材表面に形成することができる皮膜形成用組成物が記載されるが、光触媒を用いるものであり、また皮膚に用いるものではなかった。 In addition, as an invention characterized by the formation of antibacterial film, Patent Document 2 discloses an antibacterial and antibacterial feature characterized by mixing 80% to 97% of inorganic material powder and 20% to 3% of inorganic copper powder. There is a composition. However, it cannot be used on the skin. Patent Document 3 discloses a dental composition for preventing caries for forming a film made of a water-soluble and / or aqueous emulsion polymer, but it cannot be used for outer skins such as fingers. Patent Document 4 describes a film-forming composition that can form a transparent and highly durable film on the surface of a substrate by drying, but it uses a photocatalyst and does not use it on the skin. There wasn't.
こうした状況で、医療機関に勤務する医師や看護師らなどから、皮膚障害などを生じることなく、手軽且つ安全に乾燥状態で皮膚に常時用いることのできる新しいタイプの防菌剤が強く要望されていた。
外皮用防菌皮膜形成剤を手指に用いる際には、皮膜形成性に優れるのみならず、形成された皮膜が柔軟性に優れ手指の屈伸に追従することが求められる。皮膜形成性に劣れば手指の皮膚表面を十分に覆うことができず、柔軟性に劣れば皮膜が破損して菌付着防止性は不十分となる。本発明は、MPC重合体を含有することにより、皮膚に塗布した後に高い菌付着防止性を示す外皮用防菌皮膜形成剤の提供を課題とする。 When using the antibacterial film forming agent for outer skins for fingers, it is required not only that the film formation is excellent, but also that the formed film is excellent in flexibility and follows the bending and stretching of fingers. If the film formation is inferior, the skin surface of the finger cannot be sufficiently covered, and if the film is inferior in flexibility, the film is damaged and the bacterial adhesion preventing property is insufficient. An object of the present invention is to provide an antibacterial film-forming agent for outer skin that contains a MPC polymer and exhibits high antibacterial adhesion after being applied to the skin.
即ち、菌付着防止成分として2−メタクリロイルオキシエチルホスホリルコリン(以下、MPC単量体と略記することもある)と疎水性基含有単量体の共重合物(以下、MPC重合体と略記することもある)を含み、菌付着そのものを抑制する全く新しい外皮用防菌皮膜形成剤を提供するものである。 That is, a copolymer of 2-methacryloyloxyethyl phosphorylcholine (hereinafter sometimes abbreviated as MPC monomer) and a hydrophobic group-containing monomer (hereinafter abbreviated as MPC polymer) as a fungus adhesion preventing component. And a completely new antibacterial film forming agent for outer skin that suppresses bacterial adhesion itself.
本発明者らは、上記課題を解決するために鋭意検討を進めた結果、MPC単量体と疎水性基含有単量体により構成される共重合体を用いて外皮用防菌皮膜形成剤としたとき、高い皮膜形成能を示し、かつ柔軟性に優れるとともに、皮膚上塗布した際に高い菌付着防止性を示すことを見出し、本発明を完成するに至った。 As a result of diligent investigations to solve the above problems, the present inventors have developed an antibacterial film forming agent for outer skin using a copolymer composed of an MPC monomer and a hydrophobic group-containing monomer. As a result, the present inventors have found that it exhibits high film-forming ability and excellent flexibility, and also exhibits high antibacterial adhesion prevention properties when applied on the skin, thereby completing the present invention.
すなわち本発明は、次の〔1〕および〔2〕である。
〔1〕
2−メタクリロイルオキシエチルホスホリルコリンと式(1)
That is, the present invention includes the following [1] and [2].
[1]
2-Methacryloyloxyethyl phosphorylcholine and formula (1)
(式中、L1は、−C6H4−、−(C=O)−NH−、−O−、−(C=O)−O−及び−O−(C=O)−O−からなる群より選ばれる基を示し、L2は炭素数1〜18のアルキル基を示し、R1は水素原子又はメチル基を示す。)で示される疎水性基含有単量体により構成される重量平均分子量50000〜5000000の共重合体0.01〜10質量%と、メタノール、エタノール、イソプロパノール、ノルマルプロパノールから選ばれる一種以上の低級アルコール15〜95質量%および水を含み、塗布した後、乾燥して用いることを特徴とする外皮用防菌皮膜形成剤。 (In the formula, L 1 represents —C 6 H 4 —, — (C═O) —NH—, —O—, — (C═O) —O— and —O— (C═O) —O—). A group selected from the group consisting of: L 2 represents an alkyl group having 1 to 18 carbon atoms, and R 1 represents a hydrogen atom or a methyl group.) A coating containing 0.01 to 10% by mass of a copolymer having a weight average molecular weight of 50000 to 5000000, 15 to 95% by mass of one or more lower alcohols selected from methanol, ethanol, isopropanol, and normal propanol, and water, followed by drying. An antibacterial film-forming agent for outer skin,
〔2〕
更に殺菌剤を0.01〜5.0質量%含む、前記〔1〕項記載の外皮用防菌皮膜形成剤。
[2]
Furthermore, the antibacterial film-forming agent for an outer skin according to the item [1], further comprising 0.01 to 5.0% by mass of a bactericide.
本発明により、皮膜形成性に優れるのみならず、形成された皮膜が柔軟性に優れ、手指の屈伸に追従する菌付着防止性に優れた、乾燥して用いることのできる安全性の高い外皮用防菌皮膜形成剤を提供することができた。 According to the present invention, not only the film-forming property is excellent, but also the formed film is excellent in flexibility, excellent in anti-bacterial adhesion prevention following the bending and stretching of fingers, and can be used after drying. An antibacterial film-forming agent could be provided.
以下、本発明を更に詳細に説明する。
本発明の外皮用防菌皮膜形成剤は、MPC重合体を含有することで、高い皮膜形成能を有し、かつ柔軟性に優れ、皮膚上塗布した際に高い菌付着防止機能を示すことができる。
本発明に用いるMPC重合体は、MPC単量体とLA単量体を共重合する事により得られる。
前記、MPC単量体としては市販の2−メタクリロイルオキシエチルホスホリルコリンを好適に用いることができる。
前記、LA単量体としては、下記式(1)
Hereinafter, the present invention will be described in more detail.
The antibacterial film-forming agent for the outer skin of the present invention contains an MPC polymer, has a high film-forming ability, is excellent in flexibility, and exhibits a high anti-bacterial adhesion preventing function when applied on the skin. it can.
The MPC polymer used in the present invention is obtained by copolymerizing MPC monomer and LA monomer.
As the MPC monomer, commercially available 2-methacryloyloxyethyl phosphorylcholine can be suitably used.
As the LA monomer, the following formula (1)
(式中、L1は、−C6H4−、−(C=O)−NH−、−O−、−(C=O)−O−及び−O−(C=O)−O−からなる群より選ばれる基を示し、L2は炭素数1〜18のアルキル基を示し、R1は水素原子又はメチル基を示す。)で表される市販のLA単量体が用いられる。 (In the formula, L 1 represents —C 6 H 4 —, — (C═O) —NH—, —O—, — (C═O) —O— and —O— (C═O) —O—). A commercially available LA monomer represented by the following formula is used: L 2 represents an alkyl group having 1 to 18 carbon atoms, and R 1 represents a hydrogen atom or a methyl group.
前記、式(1)のLA単量体の具体例としては、メチル(メタ)アクリレート、エチル(メタ)アクリレート、ブチル(メタ)アクリレート、ラウリル(メタ)アクリレート、ステアリル(メタ)アクリレート、2−エチルヘキシル(メタ)アクリレート、ベンジル(メタ)アクリレート、フェノキシエチル(メタ)アクリレート、シクロヘキシル(メタ)アクリレート、ポリプロピレングリコールモノ(メタ)アクリレート、ポリテトラメチレンチレングリコールモノ(メタ)アクリレート、ポリプロピレングリコールジ(メタ)アクリレート、ポリテトラメチレンチレングリコールジ(メタ)アクリレート、ポリプロピレングリコールポリエチレングリコールモノ(メタ)アクリレート等が挙げられる。これらの単量体のうち、ブチル(メタ)アクリレート、ラウリル(メタ)アクリレート、ステアリル(メタ)アクリレートが、皮膜形成能、皮膜柔軟性及び皮膚への密着性の点からより好ましい。これらのLA単量体は、MPC重合体の製造にあたって単独でも2種以上の混合物としても用いることができる。 Specific examples of the LA monomer of the formula (1) include methyl (meth) acrylate, ethyl (meth) acrylate, butyl (meth) acrylate, lauryl (meth) acrylate, stearyl (meth) acrylate, and 2-ethylhexyl. (Meth) acrylate, benzyl (meth) acrylate, phenoxyethyl (meth) acrylate, cyclohexyl (meth) acrylate, polypropylene glycol mono (meth) acrylate, polytetramethyleneethylene glycol mono (meth) acrylate, polypropylene glycol di (meth) acrylate , Polytetramethyleneethylene glycol di (meth) acrylate, polypropylene glycol polyethylene glycol mono (meth) acrylate and the like. Of these monomers, butyl (meth) acrylate, lauryl (meth) acrylate, and stearyl (meth) acrylate are more preferable from the viewpoint of film forming ability, film flexibility, and adhesion to the skin. These LA monomers can be used alone or as a mixture of two or more in the production of the MPC polymer.
尚、LA単量体は、MPC重合体を構成したとき、MPC重合体を皮膚上に密着させる上で重要な役割を果たす。これは、LA単量体を含むことによりMPC重合体の皮膜形成性及び皮膜柔軟性が向上するためであり、また、LA単量体中の疎水性基が皮膚に対してアンカー効果を示すことにより、MPC重合体の皮膜と皮膚との密着性を向上させるためである。 The LA monomer plays an important role in adhering the MPC polymer onto the skin when it constitutes the MPC polymer. This is because inclusion of the LA monomer improves the film-forming property and film flexibility of the MPC polymer, and the hydrophobic group in the LA monomer exhibits an anchoring effect on the skin. This is for improving the adhesion between the MPC polymer film and the skin.
本発明に用いるMPC重合体は、市販品を用いても良いが、MPC単量体とLA単量体を含む単量体組成物を、溶液重合、乳化重合、懸濁重合等、公知の方法に従って重合することによっても得ることができる。例えば溶液重合の場合、単量体組成物を低級アルコールなどの有機溶媒中に溶解し、窒素、アルゴン等不活性ガスの雰囲気下、アゾ化合物や過酸化物等のラジカル重合開始剤を添加して加熱、攪拌することにより、本発明に用いるMPC重合体を得ることができる。 The MPC polymer used in the present invention may be a commercially available product, but a known method such as solution polymerization, emulsion polymerization, suspension polymerization or the like for a monomer composition containing an MPC monomer and an LA monomer. Can also be obtained by polymerization according to For example, in the case of solution polymerization, the monomer composition is dissolved in an organic solvent such as lower alcohol, and a radical polymerization initiator such as an azo compound or a peroxide is added under an atmosphere of an inert gas such as nitrogen or argon. The MPC polymer used in the present invention can be obtained by heating and stirring.
本発明の外皮用防菌皮膜形成剤に用いるMPC重合体は、MPC単量体とLA単量体により構成されるものであるが、好ましくは、MPC単量体に由来する共重合組成比が10〜90モル%、LA単量体に由来する共重合組成比が90〜10モル%である共重合体が用いられる。即ち、MPC重合体中における各単量体の共重合組成比については、10:90〜90:10(MPC単量体:LA単量体、モル%)の範囲で適宜選定することができるが、皮膜形成性と菌付着防止機能の点から、各単量体由来の共重合組成比が30:70〜80:20(モル%)の範囲がより好ましい。MPC単量体の共重合組成比が10モル%より小さい場合、十分な菌付着防止能が得られないことがあり、LA単量体の共重合組成比が10モル%より小さい場合、十分な皮膜形成能が得られないことがあるので好ましくない。 The MPC polymer used for the antibacterial film-forming agent for outer skin of the present invention is composed of MPC monomer and LA monomer, but preferably has a copolymer composition ratio derived from MPC monomer. A copolymer having a copolymer composition ratio of 90 to 10 mol% derived from 10 to 90 mol% and LA monomer is used. That is, the copolymer composition ratio of each monomer in the MPC polymer can be appropriately selected within the range of 10:90 to 90:10 (MPC monomer: LA monomer, mol%). The copolymer composition ratio derived from each monomer is more preferably in the range of 30:70 to 80:20 (mol%) from the viewpoints of film-forming properties and fungus adhesion prevention function. When the copolymerization composition ratio of the MPC monomer is less than 10 mol%, sufficient ability to prevent bacterial adhesion may not be obtained, and when the copolymerization composition ratio of the LA monomer is less than 10 mol%, sufficient Since film forming ability may not be obtained, it is not preferable.
本発明の外皮用防菌皮膜形成剤に用いるMPC重合体の重量平均分子量については、50000〜5000000の範囲で適宜選定することができるが、皮膜形成性と取り扱いやすさの点から、100000〜3000000の範囲がより好ましい。
MPC重合体の外皮用防菌皮膜形成剤への配合量については、0.01〜10質量%の範囲で適宜選定することができるが、手指への塗布時における使用感の点から、0.05〜5質量%の範囲がより好ましい。
本発明の外皮用防菌皮膜形成剤の製造に用いるMPC重合体の形態としては、粉状、溶液状又は均一分散液体状のいずれでもよい。
The weight average molecular weight of the MPC polymer used for the antibacterial film-forming agent for the outer skin of the present invention can be appropriately selected within the range of 50,000 to 5000000, but from the viewpoint of film forming property and ease of handling, 100,000 to 3000000. The range of is more preferable.
The blending amount of the MPC polymer in the antibacterial film forming agent for the outer skin can be appropriately selected within a range of 0.01 to 10% by mass. The range of 05-5 mass% is more preferable.
The form of the MPC polymer used for the production of the antibacterial film-forming agent for the outer skin of the present invention may be any of powder, solution or uniformly dispersed liquid.
本発明の外皮用防菌皮膜形成剤は、皮膚に対して均一に塗布しやすくする目的から低級アルコールを含有する。低級アルコールを含有することにより、製剤の界面張力が低下して皮膚上に広がりやすくなるため、使用感が向上するとともに、皮膜形成時の均一性も向上する。本発明に用いる低級アルコールとしては、メタノール、エタノール、イソプロパノール、ノルマルプロパノールが挙げられ、使用に際しては1種または2種以上の低級アルコールを混合して用いても良い。このうち、臭いや使用感の観点から、エタノール及び/又はイソプロパノールがより好ましい。低級アルコールの含有割合は、本発明の外皮用防菌皮膜形成剤中、15〜95質量%、好ましくは25〜85質量%の範囲である。該含有割合が15質量%未満の場合、得られる皮膜にムラが生じる。また、該含有割合が95質量%を超えて配合しても皮膜の均一性に及ぼす効果は変らない。 The antibacterial film-forming agent for outer skin of the present invention contains a lower alcohol for the purpose of facilitating uniform application to the skin. By containing a lower alcohol, the interfacial tension of the preparation is lowered and easily spreads on the skin, so that the feeling in use is improved and the uniformity during film formation is also improved. Examples of the lower alcohol used in the present invention include methanol, ethanol, isopropanol, and normal propanol. When used, one or more kinds of lower alcohols may be mixed. Among these, ethanol and / or isopropanol are more preferable from the viewpoints of odor and usability. The content rate of a lower alcohol is 15-95 mass% in the antibacterial film-forming agent for outer skins of this invention, Preferably it is the range of 25-85 mass%. When the content is less than 15% by mass, unevenness occurs in the obtained film. Further, even if the content ratio exceeds 95% by mass, the effect on the uniformity of the film does not change.
本発明の外皮用防菌皮膜形成剤は、MPC重合体と低級アルコールの他に、水を含有する。低級アルコールと水の混合溶媒を用いることにより、皮膚に対するMPC重合体の密着性を向上させることができる。これは製剤の乾燥時において、低級アルコールと水の蒸散速度が異なることを利用して、MPC重合体中のホスホリルコリン基を空気界面に稠密に配向させ、また、疎水性基を皮膚界面に効果的に配向させるためである。本発明に用いる水については特に限定されないが、不純物の含有量が少ないイオン交換水、精製水及び注射用水などを用いることが好ましい。水の含有割合は、本発明の外皮用防菌皮膜形成剤中、5〜85質量%、好ましくは15〜75質量%の範囲である。該含有割合が5質量%未満の場合若しくは、85質量%を超えて配合する場合、皮膚に対するMPC重合体の密着性が低下するので好ましくない。 The antibacterial film-forming agent for outer skin of the present invention contains water in addition to the MPC polymer and the lower alcohol. By using a mixed solvent of lower alcohol and water, the adhesion of the MPC polymer to the skin can be improved. This is because the transpiration rate of lower alcohol and water is different when the preparation is dried, and the phosphorylcholine group in the MPC polymer is oriented closely to the air interface, and the hydrophobic group is effective at the skin interface. This is for the purpose of orientation. The water used in the present invention is not particularly limited, but it is preferable to use ion-exchanged water, purified water, water for injection, or the like having a low impurity content. The content rate of water is 5-85 mass% in the antibacterial film-forming agent for outer skins of this invention, Preferably it is the range of 15-75 mass%. When the content ratio is less than 5% by mass or when the content exceeds 85% by mass, the adhesion of the MPC polymer to the skin is undesirably reduced.
また、本発明の外皮用防菌皮膜形成剤は、本発明の目的を逸脱しない範囲で、湿潤剤を含んでも良い。該湿潤剤としては、例えば、エチレングリコール、プロピレングリコール、ジプロピレングリコール、1,3−ブチレングリコール、1,4−ブチレングリコール、ペンチレングリコール、ヘキシレングリコール、イソプレングリコール、エチルヘキサンジオール、イソペンチルジオール、グリセリン、ジグリセリン、ポリグリセリン、ソルビトール、キシリトール、マルチトール、マンニトール、エリスリトール等のポリオール系化合物類が挙げられ、使用に際しては、単独又は2種以上の混合物として用いることができる。これら湿潤剤の中でも、外皮への馴染みの良さから、プロピレングリコール、ジプロピレングリコール、1,3−ブチレングリコール及びグリセリンがより好ましい。湿潤剤を含有させる場合の割合は、本発明の所望の効果を損なうことのない範囲で、外皮用防菌皮膜形成剤の全量当り、通常0.1〜5.0質量%が好ましい。 Moreover, the antibacterial film-forming agent for outer skin of the present invention may contain a wetting agent without departing from the object of the present invention. Examples of the wetting agent include ethylene glycol, propylene glycol, dipropylene glycol, 1,3-butylene glycol, 1,4-butylene glycol, pentylene glycol, hexylene glycol, isoprene glycol, ethylhexanediol, and isopentyldiol. And polyol compounds such as glycerin, diglycerin, polyglycerin, sorbitol, xylitol, maltitol, mannitol, erythritol and the like, and can be used alone or as a mixture of two or more. Among these wetting agents, propylene glycol, dipropylene glycol, 1,3-butylene glycol and glycerin are more preferable because of their familiarity with the outer skin. The ratio when the wetting agent is contained is usually 0.1 to 5.0% by mass with respect to the total amount of the antibacterial film forming agent for the outer skin as long as the desired effect of the present invention is not impaired.
本発明の外皮用防菌皮膜形成剤は、更に、外皮上に元々存在する菌を減少させるために殺菌剤を好ましく含んでも良い。本発明に用いる殺菌剤としては、MPC重合体の皮膜形成性を阻害しないものを用いることができ、塩化ベンザルコニウム、塩化ベンゼトニウム、塩化セチルピリジニウム等のカチオン性界面活性剤、グルコン酸クロルヘキシジン、塩酸クロルヘキシジン等のビグアナイド系化合物、ヨウ素イオン、ヨウドホルム、ポビドンヨード等のヨウ素系化合物、銀イオン等の無機系化合物、クレゾール、イソプロピルメチルフェノール等のフェノール系化合物を配合することができる。これらの使用に際しては、外皮用防菌皮膜形成剤中、0.01〜5.0質量%の範囲で1種又は2種以上を混合して用いることができる。 The antibacterial film-forming agent for outer skin of the present invention may preferably further contain a bactericidal agent in order to reduce the bacteria originally present on the outer skin. As the bactericidal agent used in the present invention, those that do not inhibit the film-forming property of the MPC polymer can be used. Cationic surfactants such as benzalkonium chloride, benzethonium chloride, cetylpyridinium chloride, chlorhexidine gluconate, hydrochloric acid A biguanide compound such as chlorhexidine, an iodine compound such as iodine ion, iodoform, and povidone iodine, an inorganic compound such as silver ion, and a phenol compound such as cresol and isopropylmethylphenol can be blended. In using these, 1 type or 2 types or more can be mixed and used in the range of 0.01-5.0 mass% in the antibacterial film-forming agent for outer skins.
尚、本発明の外皮用防菌皮膜形成剤は、前記成分の他に、公知の外用剤に使用される添加剤を含有させても良い。前記添加剤としては、例えば、増粘剤、起泡剤、エアゾール剤、有機酸、酸化防止剤、安定剤、防腐剤、金属イオン封鎖剤、香料、色素、色材等を本発明の性能を損なわない範囲で配合することができる。 In addition, the antibacterial film-forming agent for outer skin of the present invention may contain additives used for known external preparations in addition to the above components. Examples of the additive include a thickener, a foaming agent, an aerosol agent, an organic acid, an antioxidant, a stabilizer, an antiseptic, a sequestering agent, a fragrance, a dye, and a coloring material. It can mix | blend in the range which is not impaired.
本発明の外皮用防菌皮膜形成剤の製造に際しては、前記各成分を適宜混合しても良いが、例えば次のように製造することもできる。MPC重合体の形態が粉状の場合は、水に加えてからよく攪拌混合し、均一溶解させる。MPC重合体の形態が溶液状または均一分散液体状の場合は、水に加えて攪拌混合して均一にする。このようにして得られたMPC重合体溶液に対して低級アルコールを加えて混和することにより、外皮用防菌皮膜形成剤を簡便に得ることができる。
また、殺菌剤、添加剤など他成分を加える場合は、あらかじめこれらの成分を水又はアルコールに加えて攪拌混合し、よく溶解させた後、MPC重合体溶液と混和することにより、外皮用防菌皮膜形成剤を簡便に得ることができる。
In the production of the antibacterial film forming agent for an outer skin of the present invention, the respective components may be appropriately mixed. For example, it can also be produced as follows. When the MPC polymer is in the form of powder, it is added to water and mixed well with stirring to dissolve it uniformly. When the MPC polymer is in the form of a solution or a uniformly dispersed liquid, it is made uniform by stirring and mixing in addition to water. By adding a lower alcohol to the MPC polymer solution thus obtained and mixing it, a bacteriostatic film-forming agent for the outer skin can be easily obtained.
When adding other components such as bactericides and additives, add these components to water or alcohol in advance, stir and mix, dissolve well, and then mix with the MPC polymer solution to prevent bacteriolysis for the skin. A film-forming agent can be easily obtained.
本発明の外皮用防菌皮膜形成剤の形状については、使用時の簡便さや安全性の観点などから、ディスペンサーポンプ付き容器に充填した液吐出型、スプレーポンプ付き容器に充填した噴霧型、フォーマーポンプ付き容器又はエアゾール容器に充填した泡吐出型が望ましい。いずれの場合においても、使用に際しては外皮用防菌皮膜形成剤を1〜3mL程度の適量を取り、手に擦り込みながら塗布した後、乾燥することにより効果が得られる。特に、外皮用防菌皮膜形成剤が乾燥せず、皮膚が濡れたままでは、物品等への接触により、塗布面から薬剤がふき取られ、防菌皮膜が形成され難いので、室温で風に当てるなどして、皮膚上の外皮用防菌皮膜形成剤を十分に乾かして使用するのが良い。皮膚に塗布した後、乾燥が不十分であると、菌付着防止効果が十分に発揮されない場合があるので注意が必要である。 Regarding the shape of the antibacterial film forming agent for the outer skin of the present invention, from the viewpoint of convenience and safety during use, a liquid discharge type filled in a container with a dispenser pump, a spray type filled in a container with a spray pump, a former A foam discharge type filled in a container with a pump or an aerosol container is desirable. In any case, in use, the effect can be obtained by taking an appropriate amount of about 1 to 3 mL of the antibacterial film-forming agent for the skin, applying it while rubbing it into the hand, and drying. In particular, if the antibacterial film forming agent for the outer skin does not dry and the skin is still wet, the drug is wiped off from the coated surface by contact with the article, etc. It is preferable to dry the antibacterial film-forming agent for the skin on the skin. Care must be taken since the effect of preventing adhesion of bacteria may not be sufficiently exerted if the drying is insufficient after application to the skin.
以下、本発明を実施例、比較例により更に詳細に説明する。
実施例1
精製水73.0gに2−メタクリロイルオキシエチルホスホリルコリン(MPC)とn−ブチルメタクリレート(BMA)の共重合体(MPC/BMA=8/2)(以下、MPC重合体Aと略記)の5%水溶液2.0g(ポリマー固形分0.1g、精製水1.9gを含有)を添加し、系が均一になるまで攪拌した。次いでエタノール25.0gを添加し、系が均一になるまで攪拌し、外皮用防菌皮膜形成剤100gを調製した。これについて、次の(外皮用防菌皮膜形成剤の皮膜形成性の評価)、(外皮用防菌皮膜形成剤の皮膜柔軟性及び皮膜均一性の評価)、(外皮用防菌皮膜形成剤の菌付着防止機能の評価)を行い、判定結果を表1に記した。
Hereinafter, the present invention will be described in more detail with reference to Examples and Comparative Examples.
Example 1
A 5% aqueous solution of 2-methacryloyloxyethyl phosphorylcholine (MPC) and n-butyl methacrylate (BMA) copolymer (MPC / BMA = 8/2) (hereinafter abbreviated as MPC polymer A) in 73.0 g of purified water. 2.0 g (polymer solid content 0.1 g, containing purified water 1.9 g) was added and stirred until the system was uniform. Next, 25.0 g of ethanol was added and stirred until the system was uniform to prepare 100 g of an antibacterial film forming agent for outer skin. About this, the following (evaluation of the film-forming property of the antibacterial film-forming agent for skin), (evaluation of the film flexibility and film uniformity of the anti-bacterial film-forming agent for skin), Evaluation of fungus adhesion prevention function) was performed, and the determination results are shown in Table 1.
(外皮用防菌皮膜形成剤の皮膜形成性の評価)
本発明の外皮用防菌皮膜形成剤の皮膜形成性について、次の方法により評価した。即ち、外皮用防菌皮膜形成剤を所定量取り、フッ素樹脂加工シャーレに展開して室温で乾燥させた後、40℃にて減圧乾燥させた。乾燥後、固形物がフィルム状で得られた場合は皮膜形成性あり、フィルムとして得られなかった場合(糊状や粉状等)は皮膜形成性なしと判定した。
<判定結果;皮膜形成性>
フィルム化する:○、フィルム化しない:×
(Evaluation of film forming property of antibacterial film forming agent for outer skin)
The film forming property of the antibacterial film forming agent for outer skin of the present invention was evaluated by the following method. That is, a predetermined amount of the antibacterial film-forming agent for the outer skin was taken, spread on a fluororesin-treated petri dish, dried at room temperature, and then dried at 40 ° C. under reduced pressure. After drying, when the solid was obtained in the form of a film, it was judged that there was film-forming property, and when it was not obtained as a film (such as paste or powder), it was judged that there was no film-forming property.
<Judgment result; film-forming property>
Filmed: ○, not filmed: ×
(外皮用防菌皮膜形成剤の皮膜柔軟性及び皮膜均一性の評価)
本発明の外皮用防菌皮膜形成剤の皮膜柔軟性について、次の方法により評価した。即ち、本発明の外皮用防菌皮膜形成剤を所定量取り、人工皮革(白色)に塗布して室温で乾燥させた後、気温30℃、相対湿度65%の環境下に15分置いた後、直角に折り曲げて、皮膜層に亀裂が生じるか評価した。亀裂が生じなかった場合は柔軟性あり、亀裂が生じた場合は柔軟性なしと判定した。
また、皮膜均一性を次の方法により評価した。即ち、あらかじめインクで着色した外皮用防菌皮膜形成剤を用いて、前記と同様の方法にて人工皮革に塗布し、乾燥後、色ムラを目視判定して皮膜形成均一性を評価した。
<判定結果;皮膜柔軟性>
亀裂が生じなかった:○、亀裂が生じた:×
<判定結果;皮膜均一性>
ムラなし:○、ムラあり:×
(Evaluation of film flexibility and film uniformity of antibacterial film forming agent for skin)
The film flexibility of the antibacterial film forming agent for outer skin of the present invention was evaluated by the following method. That is, after taking a predetermined amount of the antibacterial film-forming agent for outer skin of the present invention, applying it to artificial leather (white) and drying at room temperature, it was placed in an environment with an air temperature of 30 ° C. and a relative humidity of 65% for 15 minutes. The film was bent at a right angle to evaluate whether a crack occurred in the coating layer. It was determined that there was flexibility when no crack occurred, and that there was no flexibility when crack occurred.
The film uniformity was evaluated by the following method. That is, using an antibacterial film forming agent for outer skin colored in advance in advance, it was applied to artificial leather by the same method as described above, and after drying, color unevenness was visually judged to evaluate film formation uniformity.
<Judgment result; film flexibility>
No crack occurred: ○, Crack occurred: ×
<Judgment result; film uniformity>
No unevenness: ○, unevenness: ×
(外皮用防菌皮膜形成剤の菌付着防止機能の評価)
市販の消毒用エタノール3mLを手指に取り20秒間擦りこむ操作を2回行い、手指が十分に乾燥した後、パームスタンプ(日研生物医学研究所製、一般細菌(SCD)培地)上に手のひらをスタンプした。次に本発明の外皮用防菌皮膜形成剤3mLを手指に取り20秒間擦りこむ操作を2回行い、被験者にはそのまま通常どおりに生活してもらい、3時間後、同様にスタンプを行った。各製剤について、被験者5名で同じ操作を行った。スタンプ後の各培地を37℃のインキュベータ内にて24時間培養し、培地上に菌コロニー数をカウントした。消毒直後のコロニー数(A)及び外皮用防菌皮膜形成剤塗布後3時間経過時点でのコロニー数(B)をカウントし、それぞれの対数値(logA、logB)を算出した。logBからlogAを差し引いた値を「対数増加値」とし、被験者5名について平均をとって「平均対数増加値」を算出した。菌付着防止機能について、前記の平均対数増加値が0.3未満を著効、0.3以上1.0未満を有効、1.0以上を無効と判定した。
<判定結果;菌付着防止機能>
著効:◎、有効:○、無効:×
(Evaluation of antibacterial function of antibacterial film forming agent for outer skin)
Take 3 mL of commercially available disinfectant ethanol and rub it for 20 seconds twice. After the fingers are sufficiently dried, put the palm on the palm stamp (Niken Biomedical Research Institute, General Bacterium (SCD) Medium). Stamped. Next, the operation of taking 3 mL of the antibacterial film-forming agent for outer skin of the present invention with a finger and rubbing for 20 seconds was performed twice, and the subject was allowed to live as usual, and after 3 hours, stamping was similarly performed. For each preparation, the same operation was performed by 5 subjects. Each medium after stamping was cultured in an incubator at 37 ° C. for 24 hours, and the number of fungal colonies was counted on the medium. The number of colonies immediately after disinfection (A) and the number of colonies (B) after 3 hours from the application of the antibacterial film-forming agent for outer skin were counted, and the respective logarithmic values (logA, logB) were calculated. A value obtained by subtracting log A from log B was defined as “log increase value”, and an average of 5 subjects was calculated to calculate “average log increase value”. Regarding the fungus adhesion prevention function, the average log increase value was determined to be significantly less than 0.3, 0.3 to less than 1.0 was effective, and 1.0 or more was determined to be invalid.
<Judgment result; fungus adhesion prevention function>
Remarkable: ◎, valid: ○, invalid: ×
(表の説明)
*ポリマー成分
MPC重合体A:2−メタクリロイルオキシエチルホスホリルコリン(MPC)とn−ブチルメタクリレート(BMA)の共重合体(MPC/BMA=8/2)
MPC重合体B:MPCとBMAの共重合体(MPC/BMA=3/7)
MPC重合体C:MPCとラウリルメタクリレート(LMA)の共重合体(MPC/LMA=3/7)
MPC重合体D:MPCとステアリルメタクリレート(SMA)の共重合体(MPC/SMA=3/7)
(Explanation of the table)
* Polymer component MPC polymer A: copolymer of 2-methacryloyloxyethyl phosphorylcholine (MPC) and n-butyl methacrylate (BMA) (MPC / BMA = 8/2)
MPC polymer B: copolymer of MPC and BMA (MPC / BMA = 3/7)
MPC polymer C: copolymer of MPC and lauryl methacrylate (LMA) (MPC / LMA = 3/7)
MPC polymer D: copolymer of MPC and stearyl methacrylate (SMA) (MPC / SMA = 3/7)
**平均対数増加値(被験者5名)
={log(塗布後3時間経過時点でのコロニー数)−log(消毒直後のコロニー数)}÷5
判定基準:0.3未満:著効、0.3以上1.0未満:有効、1.0以上:無効
** Average log increase (5 subjects)
= {Log (number of colonies after 3 hours after application) -log (number of colonies immediately after disinfection)} / 5
Criteria: Less than 0.3: Excellent, 0.3 or more and less than 1.0: Valid, 1.0 or more: Invalid
実施例2〜7
配合成分の種類及び配合量を表1に示すように変更した以外は、実施例1に記載の方法に準じて、実施例2〜7の外皮用防菌皮膜形成剤、各100gを調製した。これについて、実施例1と同様に(外皮用防菌皮膜形成剤の皮膜形成性の評価)、(外皮用防菌皮膜形成剤の皮膜柔軟性及び皮膜均一性の評価)、(外皮用防菌皮膜形成剤の菌付着防止機能の評価)を行い、判定結果を表1に記した。
Examples 2-7
100 g of the antibacterial film-forming agent for outer skins of Examples 2 to 7 were prepared according to the method described in Example 1 except that the types and amounts of the ingredients were changed as shown in Table 1. About this, it is the same as Example 1 (evaluation of the film forming property of the antibacterial film forming agent for the outer skin), (evaluation of the film flexibility and film uniformity of the antibacterial film forming agent for the outer skin), Evaluation of the function of the film-forming agent for preventing bacterial adhesion was performed, and the determination results are shown in Table 1.
実施例8
精製水64.9gにグリセリン0.1gを添加し、系が均一になるまで攪拌した。次いでMPC重合体Aの5%水溶液10.0g(ポリマー固形分0.5g、精製水9.5gを含有)を添加し、系が均一になるまで攪拌した。次いでエタノール25.0gを添加し、系が均一になるまで攪拌し、外皮用防菌皮膜形成剤100gを調製した。これについて、実施例1と同様に(外皮用防菌皮膜形成剤の皮膜形成性の評価)、(外皮用防菌皮膜形成剤の皮膜柔軟性及び皮膜均一性の評価)、(外皮用防菌皮膜形成剤の菌付着防止機能の評価)を行い、判定結果を表1に記した。
Example 8
To 64.9 g of purified water, 0.1 g of glycerin was added and stirred until the system was uniform. Next, 10.0 g of a 5% aqueous solution of MPC polymer A (containing 0.5 g of polymer solids and 9.5 g of purified water) was added and stirred until the system was uniform. Next, 25.0 g of ethanol was added and stirred until the system was uniform to prepare 100 g of an antibacterial film forming agent for outer skin. About this, it is the same as Example 1 (evaluation of the film forming property of the antibacterial film forming agent for the outer skin), (evaluation of the film flexibility and film uniformity of the antibacterial film forming agent for the outer skin), Evaluation of the function of the film-forming agent for preventing bacterial adhesion was performed, and the determination results are shown in Table 1.
実施例9〜11
グリセリンに替えてグルコン酸クロルヘキシジン、ヒドロキシプロピルセルロース、ポリソルベート80を用いて、配合量を表1に示すように変更した以外は、実施例8に記載の方法に準じて、実施例9〜11の外皮用防菌皮膜形成剤、各100gを調製した。これについて、実施例1と同様に(外皮用防菌皮膜形成剤の皮膜形成性の評価)、(外皮用防菌皮膜形成剤の皮膜柔軟性及び皮膜均一性の評価)、(外皮用防菌皮膜形成剤の菌付着防止機能の評価)を行い、判定結果を表1に記した。
Examples 9-11
Using the chlorhexidine gluconate, hydroxypropyl cellulose, polysorbate 80 instead of glycerin, and changing the blending amount as shown in Table 1, according to the method described in Example 8, the outer skin of Examples 9-11 100 g of each antibacterial film forming agent was prepared. About this, it is the same as Example 1 (evaluation of the film forming property of the antibacterial film forming agent for the outer skin), (evaluation of the film flexibility and film uniformity of the antibacterial film forming agent for the outer skin), Evaluation of the function of the film-forming agent for preventing bacterial adhesion was performed, and the determination results are shown in Table 1.
比較例1〜5
配合成分の種類及び配合量を表2に示すように変更した以外は、実施例1に記載の方法に準じて、比較例1〜5のサンプル、各100gを調製した。これについて、実施例1と同様に(外皮用防菌皮膜形成剤の皮膜形成性の評価)、(外皮用防菌皮膜形成剤の皮膜柔軟性及び皮膜均一性の評価)、(外皮用防菌皮膜形成剤の菌付着防止機能の評価)を行い、判定結果を表2に記した。
Comparative Examples 1-5
Samples of Comparative Examples 1 to 5 and 100 g of each were prepared according to the method described in Example 1 except that the types and amounts of the ingredients were changed as shown in Table 2. About this, it is the same as Example 1 (evaluation of the film forming property of the antibacterial film forming agent for the outer skin), (evaluation of the film flexibility and film uniformity of the antibacterial film forming agent for the outer skin), Evaluation of the anti-fungus adhesion function of the film-forming agent) was performed, and the determination results are shown in Table 2.
以上の実施例、比較例より、本発明の外皮用防菌皮膜形成剤は、比較例で用いたサンプルよりも皮膜の均一性に優れ、更に菌付着防止機能にも優れることが明らかとなった。皮膜の均一性が維持されない場合、防菌皮膜が形成されず、菌付着防止機能が発揮されない為、皮膜の均一性が得られることは本発明にとって重要である。本発明の外皮用防菌皮膜形成剤においては、MPC重合体と低級アルコール、水との配合割合を適切に制御していることから、ホスホリルコリン基を空気界面に稠密に配向させることができ、皮膚上でホスホリルコリン基を持つ皮膜の均一性を維持し、防菌効果を発揮することができた。 From the above Examples and Comparative Examples, it was revealed that the antibacterial film forming agent for outer skin of the present invention is superior in the uniformity of the film than the sample used in the Comparative Example, and further excellent in the function of preventing bacterial adhesion. . When the uniformity of the film is not maintained, the antibacterial film is not formed, and the function of preventing the adhesion of bacteria is not exhibited. Therefore, it is important for the present invention to obtain the film uniformity. In the antibacterial film-forming agent for outer skin of the present invention, since the blending ratio of MPC polymer, lower alcohol and water is appropriately controlled, the phosphorylcholine group can be densely oriented at the air interface, and the skin It was possible to maintain the uniformity of the film having phosphorylcholine groups and to exert antibacterial effects.
Claims (2)
2−メタクリロイルオキシエチルホスホリルコリンと下記式(1)で示される疎水性基含有単量体により構成される重量平均分子量50000〜5000000の共重合体0.01〜10質量%と、
メタノール、エタノール、イソプロパノール、ノルマルプロパノールから選ばれる一種以上の低級アルコール15〜95質量%と、
水15〜75質量%と
を含む外皮用防菌皮膜形成剤。 It is an antibacterial film-forming agent for the skin that is used after being applied and dried,
A copolymer having a weight average molecular weight of 50,000 to 5,000,000, composed of 2-methacryloyloxyethyl phosphorylcholine and a hydrophobic group-containing monomer represented by the following formula (1);
15 to 95% by mass of one or more lower alcohols selected from methanol, ethanol, isopropanol, and normal propanol ;
15-75% by weight of water
An antibacterial film-forming agent for outer skin containing
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2008168381A JP5359059B2 (en) | 2008-06-27 | 2008-06-27 | Antibacterial film forming agent for outer skin |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2008168381A JP5359059B2 (en) | 2008-06-27 | 2008-06-27 | Antibacterial film forming agent for outer skin |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2010005161A JP2010005161A (en) | 2010-01-14 |
JP5359059B2 true JP5359059B2 (en) | 2013-12-04 |
Family
ID=41586326
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2008168381A Active JP5359059B2 (en) | 2008-06-27 | 2008-06-27 | Antibacterial film forming agent for outer skin |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP5359059B2 (en) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP6558133B2 (en) * | 2015-08-05 | 2019-08-14 | 日油株式会社 | Cosmetic stain adhesion preventing agent and oral composition |
JP6264624B1 (en) * | 2016-08-24 | 2018-01-24 | 株式会社ファインテック | Antibacterial / mold / deodorant, vaporizing humidifier using the same, and antibacterial / mold / deodorant method |
WO2021172162A1 (en) * | 2020-02-26 | 2021-09-02 | 日油株式会社 | Disinfecting composition |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2003180801A (en) * | 2001-12-21 | 2003-07-02 | Yoichiro Miyake | Antimicrobial material |
JP2005314336A (en) * | 2004-04-30 | 2005-11-10 | Nof Corp | Composition for disinfecting skin and method for mitigating skin irritation |
JP4853238B2 (en) * | 2006-11-07 | 2012-01-11 | 日油株式会社 | Quick-drying transparent lotion for disinfection |
-
2008
- 2008-06-27 JP JP2008168381A patent/JP5359059B2/en active Active
Also Published As
Publication number | Publication date |
---|---|
JP2010005161A (en) | 2010-01-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP4876500B2 (en) | Gel hand sanitizer | |
EP2240031B1 (en) | Antimicrobial compositions | |
US8821910B2 (en) | Alkylaminoalkyl oligomers as broad-spectrum antimicrobial agent | |
KR101529308B1 (en) | Pre-operative skin disinfection composition and pre-operative skin disinfection method | |
KR20120047212A (en) | Antimicrobial compositions | |
MXPA04006839A (en) | Film-forming compositions and methods. | |
JP5359059B2 (en) | Antibacterial film forming agent for outer skin | |
JP5345015B2 (en) | Hand sanitizer composition | |
JP4853238B2 (en) | Quick-drying transparent lotion for disinfection | |
KR20230076642A (en) | Gel composition for film-forming sanitizer | |
EP3764975B1 (en) | A sanitizer composition | |
JP7593393B2 (en) | Disinfecting Composition | |
JP7363218B2 (en) | Disinfectant composition | |
JP2006083119A (en) | Germicidal disinfectant composition | |
WO2023120447A1 (en) | Sterilization composition and sterilization method | |
WO2022080197A1 (en) | Disinfecting composition | |
JP2024093879A (en) | Disinfectants | |
JPH08215291A (en) | Hand disinfecting composition and hand disinfecting method | |
JP2006083120A (en) | Germicidal disinfectant composition |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20110308 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20130507 |
|
RD03 | Notification of appointment of power of attorney |
Free format text: JAPANESE INTERMEDIATE CODE: A7423 Effective date: 20130626 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20130628 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A821 Effective date: 20130627 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20130806 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20130819 |
|
R150 | Certificate of patent or registration of utility model |
Free format text: JAPANESE INTERMEDIATE CODE: R150 Ref document number: 5359059 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |